Literature DB >> 14363808

Treatment of leukaemia and allied disorders with 6-mercaptopurine.

J R FOUNTAIN.   

Abstract

Entities:  

Keywords:  LEUKEMIA/therapy; PURINES/therapeutic use

Mesh：

Substances：

Year:  1955        PMID： 14363808      PMCID： PMC2061872          DOI： 10.1136/bmj.1.4922.1119

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

1.  Clinical evaluation of a new antimetabolite, 6-mercaptopurine, in the treatment of leukemia and allied diseases.

Authors:  J H BURCHENAL; M L MURPHY; R R ELLISON; M P SYKES; T C TAN; L A LEONE; D A KARNOFSKY; L F CRAVER; H W DARGEON; C P RHOADS
Journal:  Blood       Date:  1953-11       Impact factor: 22.113

2.  Antagonists of nucleic acid derivatives. VII. 2, 4-Diaminopyrimidines.

Authors:  G H HITCHINGS; E A FALCO; H VANDERWERFF; P B RUSSELL; G B ELION
Journal:  J Biol Chem       Date:  1952-11       Impact factor: 5.157

3.  The effects of the folic acid antagonists and 2,6-diaminopurine on neoplastic disease, with special reference to acute leukemia.

Authors:  J H BURCHENAL; D A KARNOFSKY; E M KINGSLEY-PILLERS; C M SOUTHAM; W P L MYERS; G C ESCHER; L F CRAVER; H W DARGEON; C P RHOADS
Journal:  Cancer       Date:  1951-05       Impact factor: 6.860

4.  The chemotherapy of acute leukaemia: a review of its present status.

Authors:  J R FOUNTAIN
Journal:  Edinb Med J       Date:  1954-03
  4 in total
  1 in total

1.  Acute leukaemia in adults treated with 6-mercaptopurine.

Authors:  D M WHITELAW; R G MOFFAT; W H PERRY; R E BECK
Journal:  Can Med Assoc J       Date:  1956-03-15       Impact factor: 8.262
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.